European Case Law Identifier: | ECLI:EP:BA:2007:T090305.20070830 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 30 August 2007 | ||||||||
Case number: | T 0903/05 | ||||||||
Application number: | 99928238.7 | ||||||||
IPC class: | A61K 38/45 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Antigenic peptides derived from telomerase | ||||||||
Applicant name: | GemVax AS | ||||||||
Opponent name: | Geron Corporation | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Right to priority (yes) Inventive step (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t050903eu1.html
Date retrieved: 17 May 2021